Mitochondrial ROS control neuronal excitability and cell fate in frontotemporal dementia
Summary
These results demonstrate mitochondrial ROS modulate glutamatergic signaling in FTD, and suggest a new therapeutic strategy. © 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
| Authors | Esteras N, Kopach O, Maiolino M, Lariccia V, Amoroso S, Qamar S, Wray S, Rusakov DA, Jaganjac M, Abramov AY |
|---|---|
| Journal | Alzheimer's & dementia : the journal of the Alzheimer's Association |
| Publication Date | 2022 Feb;18(2):318-338 |
| PubMed | 34057756 |
| PubMed Central | PMC12086756 |
| DOI | 10.1002/alz.12394 |